Morgan Stanley Tyra Biosciences, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 74,149 shares of TYRA stock, worth $753,353. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,149
Previous 68,916
7.59%
Holding current value
$753,353
Previous $1.62 Million
36.42%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding TYRA
# of Institutions
112Shares Held
43.1MCall Options Held
3.8KPut Options Held
6K-
Ra Capital Management, L.P. Boston, MA10.6MShares$108 Million2.39% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$42.5 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$41.5 Million89.47% of portfolio
-
Nextech Invest Ag4.06MShares$41.2 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$40.1 Million2.05% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $426M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...